Experience in managing patients of reproductive age with dyshormonal diseases of the mammary glands
DOI:
https://doi.org/10.18370/2309-4117.2020.55.109-112Keywords:
breast, mammary dysplasia, menstrual irregularities, indole-3-carbinol, Indole-FAbstract
This article presents the results of own research of the Indol-F® efficacy and safety in the treatment of 86 patients of reproductive age with a dysplasia of mammary glands for 3 months. Comparison was carried out with 50 women who were under dynamic observation. Improvement of mammary glands status (by a set of attributes) on treatment with Indole-F® was observed in 75,6% of patients, menstrual function normalization in 63,3% of patients. At the same time, spontaneous progression of symptoms was noted in more than a half of patients in the observation group.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 S. A. Lasachko, I. M. Shakalo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
